# Strategic Feedback — GPT-5.4 (R2)

**Role:** Journal editor (AER perspective)
**Model:** openai/gpt-5.4
**Timestamp:** 2026-03-25T13:28:11.535475
**Route:** OpenRouter + LaTeX
**Tokens:** 10503 in / 4002 out
**Response SHA256:** 7fe1031335b186e9

---

## 1. THE ELEVATOR PITCH

This paper asks a simple, policy-salient question: when states legalize medical aid in dying, does the mere availability of that option change how dying patients are treated more broadly—shifting care away from hospitals and toward hospice, and thereby reducing Medicare spending? Using recent staggered state adoptions, the paper’s core claim is that the answer is no: MAID legalization does not appear to meaningfully alter hospice use, inpatient spending, or total Medicare spending, despite widespread speculation that it would.

A busy economist should care because this is not really a paper about a niche bioethics policy. It is a paper about whether a highly symbolic policy changes behavior far beyond direct users—i.e., whether “option value” or norm change translates into measurable changes in healthcare utilization and public spending.

**Does the paper articulate this pitch clearly in the first two paragraphs?**  
Mostly, yes. The first two paragraphs are better than average: they identify the policy, the fiscal stakes, and the spillover hypothesis. But the opening is still a bit too “health policy seminar” and not yet sharp enough for AER. It starts with Medicare spending concentration, then moves to MAID law adoption, then to speculation. What it should do more aggressively is foreground the surprising testable claim: a law used by fewer than 0.5 percent of decedents is said to reshape end-of-life care for everyone else.

### The pitch the paper should have

“Medical aid in dying is rare in direct use, but many advocates and critics make a much larger claim: legalizing it changes how all terminal patients approach dying by normalizing palliative conversations and reducing aggressive care. This paper tests that broader ‘exit option’ hypothesis and finds no evidence that MAID legalization shifts Medicare spending toward hospice or away from inpatient care. The result matters beyond MAID itself: it suggests that highly salient legal options do not necessarily generate the large behavioral spillovers often claimed in policy debates.”

That is the AER pitch. Less “we estimate ATT with Callaway-Sant’Anna,” more “a tiny-use policy is claimed to transform a major budget category, and it doesn’t.”

---

## 2. CONTRIBUTION CLARITY

**One-sentence contribution:**  
The paper provides evidence that legalizing medical aid in dying does not measurably change the composition or level of Medicare end-of-life spending, contrary to the widely invoked “exit option” spillover hypothesis.

### Is this contribution clearly differentiated from the closest 3–4 papers?
Only partially. The paper says it is the “first causal evaluation” of MAID’s effects on Medicare spending composition, which is fine as a claim of novelty, but that is not enough by itself. “First causal evaluation” is a weak top-journal contribution unless it is attached to a question people already care deeply about. Right now the paper is differentiated at the level of method/data rather than at the level of economic insight.

The closest neighbors seem to be:
- descriptive or cost-projection work on MAID/euthanasia and healthcare costs (e.g. Emanuel 1998; Ezekiel/related cost projection discussions; Campbell et al. type descriptive state reports);
- end-of-life care and hospice spending papers (e.g. Kelley et al. on palliative care/hospice and spending; broader Dartmouth-style literature on end-of-life intensity);
- papers on option value / salience / policy availability changing behavior even without take-up;
- recent staggered-adoption policy evaluations using modern DiD.

The paper currently differentiates itself most strongly from the first category, but it does not yet cleanly explain why that should matter to economists outside this niche.

### Is the contribution framed as answering a question about the WORLD, or filling a gap in a LITERATURE?
It is mixed, and it should be more firmly about the **world**.

The strong world question is: **Do MAID laws change the behavior of the much larger population that never uses MAID?**  
The weaker literature-gap framing is: **There is no causal MAID spending paper using modern staggered DiD.**

Right now the paper contains both, but the introduction drifts too quickly toward “this contributes to three literatures,” including a methodological one. That is a downgrade. AER papers usually win on a big substantive question first.

### Could a smart economist explain what’s new after reading the introduction?
Yes, but not crisply enough. They could probably say: “It’s a staggered DiD on MAID laws and Medicare spending, and the effect is basically zero.” That is better than “another DiD paper about X,” but only marginally. The current version risks sounding like a competent null-results health policy paper with a side serving of TWFE cautionary notes.

### What would make the contribution bigger?
Be specific:

1. **Shift from average Medicare spending to end-of-life outcomes more tightly linked to the theory.**  
   The current outcomes are broad per-capita county measures. The theory is about terminal patients, advance care planning, hospice at the end of life, place of death, and aggressive treatment near death. A much bigger paper would measure:
   - spending in the last 30/90/180 days of life,
   - ICU use near death,
   - late hospice entry,
   - in-hospital death,
   - advance directive completion,
   - palliative care consults,
   - cancer vs non-cancer decedents.

2. **Connect the null to the policy’s tiny direct exposure.**  
   The strongest conceptual line is: if only a tiny share of patients ever use MAID, then large aggregate spending effects require huge spillovers. The paper should quantify that arithmetic more explicitly. What implied spillover magnitude would be needed for policy advocates’ fiscal claims to be true?

3. **Make heterogeneity central, not peripheral.**  
   The policy might plausibly matter more where MAID is clinically relevant and culturally integrated: cancer-heavy populations, high palliative care penetration, liberal health systems, or long-run adopters like Oregon/Washington. If all the action is supposed to be cultural, average short-run county-level effects are an especially hard place to find it. Either show where one would most expect effects and still find none, or acknowledge that the current design mostly rules out large average fiscal effects, not all behavioral effects.

4. **Stop trying to make the methodology a coequal contribution.**  
   The sign flip in ER visits is not enough to make this a methodological paper. It reads as borrowed importance.

---

## 3. LITERATURE POSITIONING

### Which 3–5 papers are the closest neighbors?
Closest neighbors likely include:

1. **Emanuel (1998)** and related early work/projected cost-savings discussions around physician-assisted dying.  
2. **Ezekiel / Emanuel-related MAID cost projection or normative-policy pieces** that speculate about healthcare expenditures.  
3. **Kelley et al. (2013/2015)** and adjacent palliative care/hospice spending papers on whether comfort-oriented care reduces end-of-life spending.  
4. **Finkelstein-style option value / insurance expansion work** if the paper wants to lean into “availability changes behavior,” though the current analogy is a bit stretched.  
5. **Goodman-Bacon (2021), Callaway and Sant’Anna (2021), Sun and Abraham (2021)** as methods references—but these are supporting tools, not the conversation to lead with.

If the paper wants a broader economics audience, it should also connect to:
- the literature on **whether legal rights/options matter mainly for direct users or via social spillovers**;
- the literature on **end-of-life treatment intensity and patient preferences**;
- the literature on **symbolic vs substantive policy effects**.

### How should the paper position itself relative to those neighbors?
Mostly **build on and discipline** them, not attack them.

The best stance is:
- prior work and policy commentary suggested large spillovers;
- this paper tests that empirically at scale and finds that the broader spending claims are overstated;
- therefore MAID should be discussed as an autonomy/ethics policy, not a cost-containment tool.

That is stronger than “past work was descriptive and we use better econometrics.”

### Is the paper currently positioned too narrowly or too broadly?
Oddly, both.

- **Too narrowly** in the sense that it is very tied to MAID-specific institutional detail and a particular administrative dataset.
- **Too broadly** in the sense that it claims contributions to three literatures, including option value and DiD methods, without really landing in any of them.

It needs one main conversation and one secondary conversation. The main conversation should be **end-of-life care and the real effects of MAID legalization**. The secondary conversation can be **behavioral spillovers from policy availability**.

### What literature does the paper seem unaware of?
It underplays at least three bodies of work:
1. **Economics of end-of-life care intensity**—not just hospice papers, but broader work on provider incentives, regional variation, and patient preferences.
2. **Law-and-economics / social norms / expressive effects of law**—because the “exit option hypothesis” is really an expressive-effects claim.
3. **Political economy / diffusion of social policy**—because MAID adoption is a socially charged legal change, not just a healthcare reimbursement reform.

### Is the paper having the right conversation?
Not yet fully. The most impactful framing is not “MAID and Medicare spending,” full stop. It is:

**When do highly salient legal options generate large spillover effects beyond direct take-up—and when do they not?**

That framing gives the paper a larger audience. The MAID setting becomes the sharp empirical test case.

---

## 4. NARRATIVE ARC

### Setup
End-of-life care is expensive, and policymakers are constantly searching for ways to reduce low-value intensive care and increase hospice use. MAID legalization is often said to do more than authorize a rare choice for a small number of patients: it is claimed to reorient end-of-life care more broadly.

### Tension
The direct use of MAID is tiny, so any meaningful fiscal effect must come through indirect channels—changes in conversations, norms, provider practice, and patient planning. Those channels are plausible, rhetorically powerful, and politically important, but they have not been convincingly tested.

### Resolution
The paper finds no detectable effect of MAID legalization on hospice spending, inpatient spending, total Medicare spending, or hospice utilization. The broad spillover story appears not to show up in aggregate Medicare data.

### Implications
The policy should not be sold—or attacked—as a budgetary intervention. More broadly, one should be skeptical of claims that a legally available but rarely used option will mechanically reshape behavior throughout a much larger affected population.

### Does the paper have a clear narrative arc?
It has one, but it is weakened by two problems:

1. **The methodological subplot crowds the substantive story.**  
   The ER sign-flip material is fine as a cautionary note, but it currently gets too much oxygen relative to the main question.

2. **The outcome choice is somewhat misaligned with the narrative.**  
   The theory is about dying patients; the data are county-level Medicare FFS aggregates. That doesn’t kill the paper, but it does create a gap between the story promised and the evidence delivered. The paper is strongest when interpreted as ruling out large average fiscal spillovers, not as fully adjudicating all behavioral effects of MAID legalization.

So: this is **not** merely a collection of results looking for a story. There is a story. But it needs to be cleaner, narrower, and more honest about what exactly is being tested.

The story it should be telling is:

“MAID is often argued to have system-wide effects far beyond the tiny fraction of patients who use it. If that were true in a fiscally meaningful way, we should see broad shifts in end-of-life spending patterns after legalization. We do not.”

That is enough. No need to force a second story about DiD estimator pathology.

---

## 5. THE “SO WHAT?” TEST

### What fact would I lead with at a dinner party of economists?
“States legalized MAID, and despite all the rhetoric that it would transform end-of-life care, Medicare spending patterns basically didn’t budge.”

That is the lead.

### Would people lean in or reach for their phones?
Some would lean in—especially health economists, public economists, and people interested in law/social norms. But many would only lean in if the framing is sharpened away from MAID-specific institutionalism and toward a more general lesson about policy spillovers. Right now it is interesting, but not yet irresistible.

### What follow-up question would they ask?
Probably one of these:
- “But are you looking at the right margin? Why county-level per-capita Medicare spending rather than spending near death?”
- “Could the effect be too small to see because MAID use is so rare?”
- “Maybe the effect is on patient welfare or place of death, not spending?”
- “What about Oregon—if culture matters, shouldn’t the long-run states be where you’d look?”

Those questions reveal the paper’s strategic issue: the null is only as interesting as the paper’s ability to persuade readers that this is the correct margin on which the big claims should have appeared.

### Is the null result itself interesting?
Yes, but only if framed correctly. A null here is interesting because the policy debate has made **positive claims about large indirect fiscal effects**. If those claims are central to advocacy and criticism, then showing they do not materialize is useful knowledge.

But the paper cannot present the null as “we found no significant coefficient.” It has to present it as:

**The data rule out the kind of large spending reallocation one would need for the common fiscal narratives about MAID to be true.**

That is the value of the null. Otherwise it risks feeling like a failed search for an effect.

---

## 6. STRUCTURAL SUGGESTIONS

### What would make it read better?

1. **Shorten the methodology in the introduction.**  
   The current intro spends too much capital on estimator choice. In an AER-oriented draft, the reader should get:
   - question,
   - why the answer matters,
   - headline finding,
   - why the null is informative.

   The DiD implementation can wait.

2. **Move most of the TWFE-versus-CS material out of center stage.**  
   Keep one sentence noting that modern staggered-adoption methods are used and that conventional TWFE can mislead. The detailed sign-flip discussion belongs later, and probably shorter.

3. **Front-load the economic significance of the null.**  
   The paper does this somewhat, but not early enough. The introduction should quantify what kinds of effects are ruled out and why those are the magnitudes relevant to policy rhetoric.

4. **Strengthen the motivation for the chosen outcomes.**  
   Right now the reader has to infer why county-level per-capita hospice/inpatient spending is the right place to look. Spell out the logic: if MAID truly changes end-of-life conversations system-wide, spending composition should move in these categories.

5. **The “three contributions” paragraph should be rewritten or cut down.**  
   It currently reads as defensive packing. One main contribution and one auxiliary contribution is plenty.

6. **Conclusion should do more than summarize.**  
   The current conclusion is reasonably tight, but it could better articulate the broader lesson: symbolic policies with small direct uptake may have much smaller population spillovers than public debate assumes.

### Are interesting results buried?
Yes: the **economic bounds / minimum detectable effect** discussion is more important than some of the methodology discussion and should be elevated earlier. That is what makes the null informative.

### What should be shortened or moved to appendix?
- Detailed inference discussion.
- Most of the methodological exposition around forbidden comparisons.
- Some robustness/checklist-style material.
- The standardized effect size appendix is not doing strategic work.

Also, privately: the **Acknowledgements/AI-generated paper disclosure** is a nonstarter in current top-journal practice. Regardless of the paper’s scientific merits, that feature will dominate reader attention for the wrong reason. It is not a strategic asset.

---

## 7. WHAT WOULD MAKE THIS AN AER PAPER?

The gap is mostly a combination of **framing problem** and **scope problem**, with a bit of **ambition problem**.

### Framing problem
The science may be competent, but the story is still too much “causal estimate in a new policy setting” and not enough “testing a widely asserted mechanism about how legal options change behavior.” The paper needs to make readers care about the claim being falsified.

### Scope problem
The current outcomes are broad and somewhat distant from the underlying behavioral mechanism. For AER, I would want either:
- much tighter end-of-life outcomes, or
- a more forceful argument that these broad spending aggregates are exactly where the purported spillovers must show up if they matter fiscally.

### Novelty problem
The question is novel enough within the MAID niche, but not yet broad enough in implication. “First causal evidence on MAID spending effects” is a field-journal contribution. “A sharp test of whether a rare but salient legal option reshapes broader healthcare behavior” is closer to AER territory.

### Ambition problem
The paper is careful but safe. It takes the available county-level data and asks a sensible question. That is good applied work. But AER papers usually either:
- answer a very big question,
- use unusually compelling evidence,
- or redefine the conversation.

This paper is not there yet.

### Single most impactful piece of advice
**Reframe the paper around falsifying a broad, policy-relevant claim about spillovers from a rare legal option, and then align the evidence much more tightly with that claim—preferably using outcomes closer to actual end-of-life treatment decisions rather than broad county-level spending aggregates.**

If the author can only change one thing, it should be this: **stop selling the paper as “the first causal MAID spending study using modern DiD,” and instead sell it as a decisive test of whether MAID legalization changes care for the much larger population of non-users.**

---

### Strategic Assessment

- **Current framing quality:** Adequate
- **Contribution clarity:** Somewhat fuzzy
- **Literature positioning:** Could be stronger
- **Narrative arc:** Serviceable
- **AER distance:** Medium-Far
- **Single biggest improvement:** Recast the paper as a test of broad spillover claims from MAID legalization and bring the evidence closer to actual end-of-life care decisions, not just aggregate Medicare spending.